Publications
Advanced filtering4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin
Authors: Rolf Gebhardt, Katja S Lerche, Frank Götschel, Robert Günther, Jens Kolander, Lars Teich, Sebastian Zellmer, Hans-Jörg Hofmann, Kurt Eger, Andreas Hecht, Frank Gaunitz
PubMed ID: 19228266
Date Published: 3rd Oct 2009
Scales: Intercellular
Abstract (Expand)
Glycogen synthase kinase-3beta (GSK-3beta) is a key target and effector of downstream insulin signalling. Using comparative protein kinase assays and molecular docking studies we characterize the
...
Created: 19th Jul 2012 at 14:14 Last updated: 24th Oct 2013 at 16:21
